0001567619-21-009606.txt : 20210511 0001567619-21-009606.hdr.sgml : 20210511 20210511194254 ACCESSION NUMBER: 0001567619-21-009606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mueller Brian CENTRAL INDEX KEY: 0001514980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 21912990 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2021-04-30 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001514980 Mueller Brian 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Financial Officer Common Stock 2021-04-30 5 A 0 341 62.407 A 31357 D Common Stock 2021-05-07 4 M 0 6709 28.23 A 38066 D Common Stock 2021-05-07 4 S 0 6709 79.50 D 31357 D Stock Option (Right to buy Common Stock) 28.23 2021-05-07 4 M 0 6709 0 D 2011-12-01 2021-05-30 Common Stock 6709 0.000 D Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan. Trade made pursuant to a 10b5-1 plan executed on January 29, 2021. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2021-05-11